Lambda has been detected in 29 countries with high prevalence in Peru (81% of cases) and Argentina (37%), but scientists say it poses less concern than the Delta variant. Lab studies show vaccine antibodies are less potent against Lambda than original strain, yet vaccines retain neutralizing capacity and T-cells provide additional immune protection.
O GLOBO
· Jul 10, 2021
· health
· 3 min de leitura
Medium
Apuração: Caracterizado
Lambda variant spreads in South America as scientists seek answers on vaccine efficacy
Three confirmed cases and one death linked to Lambda variant in Brazil; regional spread accelerating across South America.
◉
Health & Medicine
2697 artigos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% correspondência
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% correspondência
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% correspondência
Brazil's obesity guidelines shift focus from weight loss to disease ma…
Correio Braziliense · 90% correspondência
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% correspondência
Cobertura Relacionada
Folha de S.Paulo · Aug 18
Cisne mantém reinado como melhor sal entre paulistanos pela quinta vez
A marca Cisne vence pela quinta vez consecutiva a pesquisa Datafolha como melhor sal entre paulistanos, com 50% das menç…
Folha de S.Paulo · Aug 18 Projeto Quebrada Alimentada é eleito iniciativa de destaque em gastronomia pela FolhaO projeto Quebrada Alimentada, nascido no restaurante Mocotó durante a pandemia, foi eleito iniciativa de destaque pela …
UOL · Aug 17 Lucy Ramos revela que Globo consultou obstetra para cena de acidente na novelaA atriz Lucy Ramos revelou que a Globo consultou seu obstetra antes de gravar uma cena de acidente fatal enquanto ela es…
Estadão · Aug 17 Asma não impede atividade física; exercício regular ajuda no controle da doençaPesquisas confirmam que atividade física beneficia asmáticos, mas requer controle da doença e atenção a fatores ambienta…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Lambda COVID-19 variant spreads across South America with preliminary evidence suggesting vaccine efficacy, but limited genomic surveillance capacity hampers definitive assessment of transmissibility and severity.
Escalation Risk
low
Confidence
MED
Brazil
Peru
Argentina
Chile
South America
Latin America
Reveals structural inequalities in global health infrastructure; wealthy nations with robust genomic surveillance gain epidemiological advantage, while South American countries face capacity constraints limiting their ability to independently assess and respond to variants, potentially increasing dependence on WHO guidance and external expertise.
Similar to 2009 H1N1 pandemic response, where developing nations struggled with surveillance and response capabilities, creating information asymmetries that affected policy decisions and vaccine distribution equity.
Lente Econômica
📈
Lambda COVID-19 variant spreading in South America with preliminary evidence suggesting existing vaccines may provide neutralization, but definitive efficacy data remains unavailable, creating economic uncertainty.
Market Signal
mixed
Confidence
MED
Healthcare and pharmaceuticals
Tourism and hospitality
Retail and consumer services
Transportation and logistics
Manufacturing and supply chains
Consumers face renewed uncertainty regarding pandemic duration and travel restrictions. Potential for increased healthcare costs, delayed economic reopening in affected regions, and continued disruption to leisure and travel spending in South America.
Governments may implement renewed travel restrictions or quarantine measures; increased pressure on vaccine distribution and genomic surveillance infrastructure; potential for coordinated regional health policy responses; possible delays in economic reopening timelines in South America.